• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

固体脂质纳米粒口服递药系统用于肽类和蛋白质类药物的研究进展 III - 进食状态对去氨加压素体外释放和降解的影响

Solid lipid particles for oral delivery of peptide and protein drugs III - the effect of fed state conditions on the in vitro release and degradation of desmopressin.

机构信息

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen, Denmark.

出版信息

AAPS J. 2014 Jul;16(4):875-83. doi: 10.1208/s12248-014-9619-2. Epub 2014 May 30.

DOI:10.1208/s12248-014-9619-2
PMID:24875052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4070260/
Abstract

The effect of food intake on the release and degradation of peptide drugs from solid lipid particles is unknown and was therefore investigated in vitro using different fed state media in a lipolysis model. Desmopressin was used as a model peptide and incorporated into solid lipid particles consisting of trimyristin (TG14), tripalmitin (TG16), and tristearin (TG18), respectively. Fasted state and fed state media with varying phospholipid and bile salt concentrations, as well as fed state media with milk and oleic acid glycerides, respectively, were used as the release media. The presence of oleic acid glycerides accelerated the release of desmopressin significantly from all solid lipid particles both in the presence and absence of lipase. The presence of oleic acid glycerides also reduced the degradation rate of desmopressin, probably due to the interactions between the lipids and the protease or desmopressin. Addition of a medium chain triglyceride, trilaurin, in combination with drug-loaded lipid particles diminished the food effect on the TG18 particles, and trilaurin is therefore proposed to be a suitable excipient for reduction of the food effect. Overall, the present study shows that strategies to reduce food effect, such as adding trilaurin, for lipid particle formulations should be considered as drug release from such formulations might be influenced by the presence of food in the gastrointestinal tract.

摘要

食物摄入对肽类药物从固体脂质颗粒中释放和降解的影响尚不清楚,因此在体外使用不同的进食状态介质在脂肪分解模型中进行了研究。使用去氨加压素作为模型肽,并将其分别掺入由三硬脂酸甘油酯(TG14)、三棕榈酸甘油酯(TG16)和三硬脂酸甘油酯(TG18)组成的固体脂质颗粒中。使用禁食状态和不同磷脂和胆汁盐浓度的进食状态介质以及分别含有牛奶和油酸甘油酯的进食状态介质作为释放介质。油酸甘油酯的存在显著加速了所有固体脂质颗粒中去氨加压素的释放,无论是有脂肪酶还是没有脂肪酶的情况下。油酸甘油酯的存在还降低了去氨加压素的降解速率,这可能是由于脂质与蛋白酶或去氨加压素之间的相互作用。添加中链甘油三酯,三辛酸甘油酯,与载药脂质颗粒结合,减少了食物对 TG18 颗粒的影响,因此三辛酸甘油酯被提议作为减少食物影响的合适赋形剂。总体而言,本研究表明,对于脂质颗粒制剂,应考虑减少食物影响的策略,例如添加三辛酸甘油酯,因为此类制剂的药物释放可能会受到胃肠道中食物的影响。

相似文献

1
Solid lipid particles for oral delivery of peptide and protein drugs III - the effect of fed state conditions on the in vitro release and degradation of desmopressin.固体脂质纳米粒口服递药系统用于肽类和蛋白质类药物的研究进展 III - 进食状态对去氨加压素体外释放和降解的影响
AAPS J. 2014 Jul;16(4):875-83. doi: 10.1208/s12248-014-9619-2. Epub 2014 May 30.
2
Solid lipid particles for oral delivery of peptide and protein drugs II--the digestion of trilaurin protects desmopressin from proteolytic degradation.用于肽和蛋白质药物口服递送的固体脂质颗粒II——三月桂精的消化作用可保护去氨加压素免受蛋白水解降解。
Pharm Res. 2014 Sep;31(9):2420-8. doi: 10.1007/s11095-014-1337-z. Epub 2014 Mar 13.
3
Solid lipid particles for oral delivery of peptide and protein drugs I--elucidating the release mechanism of lysozyme during lipolysis.用于口服递送肽和蛋白质药物的固体脂质颗粒I——阐明溶菌酶在脂解过程中的释放机制。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):473-80. doi: 10.1016/j.ejpb.2013.07.017. Epub 2013 Aug 2.
4
Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.设计用于口服给药的脂基制剂:对消化的影响
AAPS PharmSciTech. 2012 Jun;13(2):637-46. doi: 10.1208/s12249-012-9787-2. Epub 2012 May 1.
5
Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.进食和禁食状态下胃肠道的体外脂肪分解:传统片剂、自乳化药物递送系统(SNEDDS)和固化SNEDDS的体外与体内关系
Eur J Pharm Sci. 2014 Jun 16;57:232-9. doi: 10.1016/j.ejps.2013.09.007. Epub 2013 Sep 18.
6
Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.脂质基质对用于口服给药的瑞格列奈载药固体脂质纳米粒的影响。
Ther Deliv. 2010 Jul;1(1):63-73. doi: 10.4155/tde.10.7.
7
Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.研究非诺贝特在生物相关介质中从脂质基质颗粒的体内吸收与体外释放之间的相关性。
Eur J Pharm Sci. 2014 Jan 23;51:204-10. doi: 10.1016/j.ejps.2013.09.022. Epub 2013 Oct 14.
8
Colloidal aspects of digestion of Pickering emulsions: Experiments and theoretical models of lipid digestion kinetics.Pickering 乳液消化的胶体方面:脂质消化动力学的实验和理论模型。
Adv Colloid Interface Sci. 2019 Jan;263:195-211. doi: 10.1016/j.cis.2018.10.002. Epub 2018 Oct 22.
9
A simplified method to screen for in-vivo performance of oral lipid formulations.一种筛选口服脂质制剂体内性能的简化方法。
J Pharm Pharmacol. 2014 May;66(5):615-23. doi: 10.1111/jphp.12182. Epub 2013 Dec 3.
10
Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN).常用的酸碱滴定法真的能量化脂质药物递送系统的酶消化率吗?以固体脂质纳米粒(SLN)为例的研究。
Eur J Pharm Biopharm. 2016 Dec;109:194-205. doi: 10.1016/j.ejpb.2016.10.007. Epub 2016 Oct 24.

引用本文的文献

1
Solid Lipid Microparticles for Oral Delivery of Catalase: Focus on the Protein Structural Integrity and Gastric Protection.固体脂质微球用于细胞色素 c 的口服递送:关注蛋白结构完整性和胃保护。
Mol Pharm. 2020 Sep 8;17(9):3609-3621. doi: 10.1021/acs.molpharmaceut.0c00666. Epub 2020 Aug 11.
2
Synergistic Catalysis by "Polymeric Microzymes and Inorganic Nanozymes": The 1+1>2 Effect for Intramolecular Cyclization of Peptides.“聚合物微酶与无机纳米酶协同催化”:肽分子内环化的1+1>2效应
Front Chem. 2017 Sep 26;5:60. doi: 10.3389/fchem.2017.00060. eCollection 2017.

本文引用的文献

1
Solid lipid particles for oral delivery of peptide and protein drugs II--the digestion of trilaurin protects desmopressin from proteolytic degradation.用于肽和蛋白质药物口服递送的固体脂质颗粒II——三月桂精的消化作用可保护去氨加压素免受蛋白水解降解。
Pharm Res. 2014 Sep;31(9):2420-8. doi: 10.1007/s11095-014-1337-z. Epub 2014 Mar 13.
2
Modification of intestinal absorption of drugs by lipoidal adjuvants.脂类佐剂对药物肠道吸收的修饰作用。
Pharm Res. 1985 May;2(3):108-18. doi: 10.1023/A:1016307231798.
3
Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.进食和禁食状态下胃肠道的体外脂肪分解:传统片剂、自乳化药物递送系统(SNEDDS)和固化SNEDDS的体外与体内关系
Eur J Pharm Sci. 2014 Jun 16;57:232-9. doi: 10.1016/j.ejps.2013.09.007. Epub 2013 Sep 18.
4
Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis.去氨加压素片剂和口服冻干制剂在单症状性夜间遗尿症儿童中的药代动力学。
Eur J Pediatr. 2014 Feb;173(2):223-8. doi: 10.1007/s00431-013-2108-2. Epub 2013 Aug 30.
5
Solid lipid particles for oral delivery of peptide and protein drugs I--elucidating the release mechanism of lysozyme during lipolysis.用于口服递送肽和蛋白质药物的固体脂质颗粒I——阐明溶菌酶在脂解过程中的释放机制。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):473-80. doi: 10.1016/j.ejpb.2013.07.017. Epub 2013 Aug 2.
6
Lipid-based formulations for oral administration of poorly water-soluble drugs.脂基制剂用于口服难溶性药物。
Int J Pharm. 2013 Aug 30;453(1):215-24. doi: 10.1016/j.ijpharm.2013.03.054. Epub 2013 Apr 8.
7
Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of danazol across Caco-2 cell monolayers.口服达那唑三油酸甘油酯溶液后腔室中的类脂双分子层相及其对达那唑跨 Caco-2 细胞单层转运的影响。
Mol Pharm. 2012 May 7;9(5):1189-98. doi: 10.1021/mp200479f. Epub 2012 Apr 24.
8
Estimation of intragastric drug solubility in the fed state: comparison of various media with data in aspirates.进食状态下胃内药物溶解度的估算:各种介质与抽吸物数据的比较。
Biopharm Drug Dispos. 2009 Sep;30(6):318-25. doi: 10.1002/bdd.670.
9
Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.通过超临界气体微雾化制备的载胰岛素和重组人生长激素脂质亚微米颗粒的生物制药特性
Int J Pharm. 2009 Sep 8;379(1):51-8. doi: 10.1016/j.ijpharm.2009.06.014. Epub 2009 Jun 21.
10
Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update.模拟人体近端胃肠道环境的溶出介质:最新进展
Pharm Res. 2008 Jul;25(7):1663-76. doi: 10.1007/s11095-008-9569-4. Epub 2008 Apr 11.